Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acid for violence in schizophrenia
NCT02552758Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- May 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia, sponsored by Shanghai Mental Health Center. Primary endpoints: Modified Overt Aggression Scale at 12 weeks and Positive and Negative Syndrome Scale at 12 weeks. Status: unknown.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02552758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552758.